GSK's latecomer Jemperli delivers head-to-head win versus Keytruda in lung cancer. What's next?
5th October 2022 Uncategorised 0 GSK’s latecomer Jemperli delivers head-to-head win versus Keytruda in lung cancer. What’s next?
aliu
Wed, 10/05/2022 – 10:45
More: GSK's latecomer Jemperli delivers head-to-head win versus Keytruda in lung cancer. What's next?
Source: fierce